The iShares U.S. Manufacturing ETF (MADE) and Tema U.S. Manufacturing & Reshoring ETF (WELD) provide targeted exposure to U.S. manufacturing trends but differ significantly in stock holdings and concentration. MADE holds 111 stocks, offering more diversification, while WELD has 22 stocks with a higher concentration in top holdings. WELD trades at a higher price-to-earnings ratio and is more volatile but holds no unprofitable firms, unlike MADE. Both ETFs recently experienced a technical 'death cross,' suggesting investors should have a medium-term perspective. The author currently holds indirect exposure through other funds and recommends these ETFs for investors understanding their unique characteristics.
The story comparing the iShares U.S. Manufacturing ETF (MADE) and Tema U.S. Manufacturing & Reshoring ETF (WELD) provides context for readers interested in manufacturing trends. For readers following Industrials-sector US stocks, here is Pluang's market snapshot as of Nov 10, 2026 22:21 WIB: out of 135 priced stocks, 48 rose and 87 fell. Notable movers include FTAI at USD 190.95 with a 1-day change of -3.72%, ENVX at USD 2.68 with a 1-day change of -3.60% and 100% sell order activity, and SWK at USD 114.45 with a 1-day change of -3.09% and 100% buy order activity.
Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...
The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...
Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...
The global nucleic acid labeling market, valued at $1.7 billion in 2025, is projected to grow to $2.8 billion by 2032 at a 7% CAGR. Growth is fueled by advances in genomics, molecular diagnostics, and personalized medicine, with increasing demand for...
MonetizeMore introduced the AdSense Policy Grader, an AI-powered tool that audits websites for compliance with Google's ad policies to prevent account bans and revenue loss. The tool offers a free basic report and a detailed paid report covering 79 p...
